India to Kenya: Cetuximab Export Trade Route

The India to Kenya Cetuximab corridor is one of India's established pharmaceutical export routes, with 22 shipments documented worth a combined $33.6K USD. The route is dominated by ASPIDA LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 24% of all export value, reflecting the consolidated nature of India's cetuximab manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $1.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with cetuximab's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 30.4%, placing it at rank #10 among India's top cetuximab export destinations globally.

On the import side, key buyers of Indian cetuximab in Kenya include TO, TO THE ORDER OF INVOICE RAISED TO:, TO THE ORDER OF INVOICE RAISED TO and 7 others. TO is the single largest importer with 7 shipments valued at $11.2K USD.

India's cetuximab exports to Kenya are driven primarily by a handful of large-scale manufacturers. ASPIDA LIFE SCIENCES PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ASPIDA LIFE SCIENCES PRIVATE LIMITED, ASPIRA BIOHEALTH LLP, R.S. SURGIPHARM PRIVATE LIMITED — together account for 65% of total trade value on this route. The average shipment value of $1.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as cetuximab injection 100mg / 20ml brand :cetuxa 100 injection batch : m1242401b and harmless medicines for injectableand capsules and tablets cetuximab 100mg 20ml injection 1 vial, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO is the largest importer with 7 shipments worth $11.2K USD — representing 33% of all cetuximab imports from India on this route. A total of 10 buyers are active on this corridor.